INVASIVE DUCTAL BREAST CARCINOMA
Clinical trials for INVASIVE DUCTAL BREAST CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE DUCTAL BREAST CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE DUCTAL BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New short radiation regimen aims to cut side effects in breast cancer treatment
Disease control Recruiting nowThis study is testing whether a shorter, higher-dose radiation treatment (APBI) given over just three days is safe and effective for women with early-stage breast cancer or DCIS who have had a lumpectomy. The goal is to see if this approach causes fewer or milder side effects com…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 17:32 UTC
-
New radiation method may boost immune attack on tumors
Symptom relief Recruiting nowThis study compares a new radiation technique called lattice radiation therapy (LRT) to standard stereotactic body radiation therapy (SBRT) for people with solid tumors that have spread to soft tissues. The goal is to see if LRT shrinks tumors better and helps the immune system f…
Matched conditions: INVASIVE DUCTAL BREAST CARCINOMA
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC